title: How does MYCN amplification make neuroblastomas behave aggressively? Still more questions than answers.
authors.affiliation: Children's Hospital of Philadelphia, PA 19104, USA. maris@email.chop.edu
authors.forename: John M
authors.initials: JM
authors.lastname: Maris
mesh_terms: D005784:Gene Amplification; D018628:Gene Dosage; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051797:Inhibitor of Differentiation Protein 2 / Q000235:genetics* / Q000378:metabolism; D000071447:N-Myc Proto-Oncogene Protein; D009447:Neuroblastoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D015513:Oncogene Proteins / Q000235:genetics* / Q000378:metabolism; D016160:Retinoblastoma Protein / Q000235:genetics / Q000378:metabolism
chemical_list: C497450:ID2 protein, human; D051797:Inhibitor of Differentiation Protein 2; C459801:MYCN protein, human; D000071447:N-Myc Proto-Oncogene Protein; D009687:Nuclear Proteins; D015513:Oncogene Proteins; D016160:Retinoblastoma Protein